Clinton Urged To Act On IPP In Argentina

13 October 1997

Ahead of US President Bill Clinton's trip to South America, SenateForeign Relations Committee Chairman Jesse Helms and House International Relations Committee Chairman Benjamin Gilman have told him that he could further the "fast track" trade negotiating authority he seeks by using the trip to insist that the interests of US companies are protected and advanced.

Among the points they said he should press is ensuring intellectual property rights, especially for drugs in Argentina.

The two foreign policy panel heads urged Argentinian President Carlos Menem to take steps to show his commitment to protection for US intellectual property. Fast-track authority would mean that trade deals negotiated by the President could not be changed by Congress, but only approved or disapproved; Mr Clinton wants to use it to expand the North American Free Trade Agreement with Mexico and Canada to include Chile.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight